Institutional investors purchased a net $504.8 thousand shares of CVM during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 5.28% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DAFNA CAPITAL MANAGEMENT LLC Bought 316.5 Thousand shares of CEL-SCI Corp
THE VANGUARD GROUP, INC. Bought 184.9 Thousand shares of CEL-SCI Corp